Previous Article | Next Article 
Antimicrobial Agents and Chemotherapy, April 2003, p. 1391-1394, Vol. 47, No. 4
0066-4804/03/$08.00+0 DOI: 10.1128/AAC.47.4.1391-1394.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.
In Vitro Activities of Piperaquine and Other 4-Aminoquinolines against Clinical Isolates of Plasmodium falciparum in Cameroon
Leonardo K. Basco1* and Pascal Ringwald2
Unité de Recherche "Paludologie Afro-tropicale," Institut de Recherche pour le Développement (IRD)-Laboratoire de Recherche sur le Paludisme, Organisation de Coordination pour la lutte contre les Endémies en Afrique Centrale (OCEAC), Yaoundé, Cameroon,1
Cluster of Communicable Diseases, Surveillance and Response, Emerging Public Health Risks including Drug Resistance, World Health Organization, Geneva, Switzerland2
Received 12 July 2002/
Returned for modification 2 December 2002/
Accepted 24 January 2003
The spread of chloroquine-resistant Plasmodium falciparum calls for a constant search for new drugs. The in vitro activity of piperaquine, a new Chinese synthetic drug belonging to the bisquinolines, was evaluated in 103 fresh clinical isolates of P. falciparum in Cameroon, Central Africa, and compared with that of other 4-aminoquinoline and Mannich base derivatives and dihydroartemisinin. Piperaquine was highly active (geometric mean 50% inhibitory concentration, 38.9 nmol/liter; range, 7.76 to 78.3 nmol/liter) and equally active (P > 0.05) against the chloroquine-sensitive and the chloroquine-resistant isolates. There was a significant but low correlation of response between chloroquine and piperaquine (r = 0.257, P < 0.05). These results suggest that further development of piperaquine, in combination with dihydroartemisinin, holds promise for use in chloroquine-resistant regions of endemicity.
* Corresponding author. Mailing address: OCEAC, B.P. 288, Yaoundé, Cameroon. Phone: 237 223 22 32. Fax: 237 223 00 61. E-mail address:
lkbasco{at}yahoo.fr.
Antimicrobial Agents and Chemotherapy, April 2003, p. 1391-1394, Vol. 47, No. 4
0066-4804/03/$08.00+0 DOI: 10.1128/AAC.47.4.1391-1394.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.
This article has been cited by other articles:
-
Mwai, L., Kiara, S. M., Abdirahman, A., Pole, L., Rippert, A., Diriye, A., Bull, P., Marsh, K., Borrmann, S., Nzila, A.
(2009). In Vitro Activities of Piperaquine, Lumefantrine, and Dihydroartemisinin in Kenyan Plasmodium falciparum Isolates and Polymorphisms in pfcrt and pfmdr1. Antimicrob. Agents Chemother.
53: 5069-5073
[Abstract]
[Full Text]
-
Karunajeewa, H. A., Mueller, I., Senn, M., Lin, E., Law, I., Gomorrai, P. S., Oa, O., Griffin, S., Kotab, K., Suano, P., Tarongka, N., Ura, A., Lautu, D., Page-Sharp, M., Wong, R., Salman, S., Siba, P., Ilett, K. F., Davis, T. M.E.
(2008). A Trial of Combination Antimalarial Therapies in Children from Papua New Guinea. NEJM
359: 2545-2557
[Abstract]
[Full Text]
-
Borrmann, S., Matsiegui, P.-B., Missinou, M. A., Kremsner, P. G.
(2008). Effects of Plasmodium falciparum Parasite Population Size and Patient Age on Early and Late Parasitological Outcomes of Antimalarial Treatment in Children. Antimicrob. Agents Chemother.
52: 1799-1805
[Abstract]
[Full Text]
-
Chen, N., Gao, Q., Wang, S., Wang, G., Gatton, M., Cheng, Q.
(2008). No Genetic Bottleneck in Plasmodium falciparum Wild-Type Pfcrt Alleles Reemerging in Hainan Island, China, following High-Level Chloroquine Resistance. Antimicrob. Agents Chemother.
52: 345-347
[Abstract]
[Full Text]
-
Karunajeewa, H. A., Ilett, K. F., Mueller, I., Siba, P., Law, I., Page-Sharp, M., Lin, E., Lammey, J., Batty, K. T., Davis, T. M. E.
(2008). Pharmacokinetics and Efficacy of Piperaquine and Chloroquine in Melanesian Children with Uncomplicated Malaria. Antimicrob. Agents Chemother.
52: 237-243
[Abstract]
[Full Text]
-
Moore, B. R., Batty, K. T., Andrzejewski, C., Jago, J. D., Page-Sharp, M., Ilett, K. F.
(2008). Pharmacokinetics and Pharmacodynamics of Piperaquine in a Murine Malaria Model. Antimicrob. Agents Chemother.
52: 306-311
[Abstract]
[Full Text]
-
Fivelman, Q. L., Adagu, I. S., Warhurst, D. C.
(2007). Effects of Piperaquine, Chloroquine, and Amodiaquine on Drug Uptake and of These in Combination with Dihydroartemisinin against Drug-Sensitive and -Resistant Plasmodium falciparum Strains. Antimicrob. Agents Chemother.
51: 2265-2267
[Abstract]
[Full Text]
-
BASCO, L. K., RINGWALD, P.
(2007). MOLECULAR EPIDEMIOLOGY OF MALARIA IN CAMEROON. XXIV. TRENDS OF IN VITRO ANTIMALARIAL DRUG RESPONSES IN YAOUNDE, CAMEROON. Am J Trop Med Hyg
76: 20-26
[Abstract]
[Full Text]
-
Naude, B., Brzostowski, J. A., Kimmel, A. R., Wellems, T. E.
(2005). Dictyostelium discoideum Expresses a Malaria Chloroquine Resistance Mechanism upon Transfection with Mutant, but Not Wild-type, Plasmodium falciparum Transporter PfCRT. J. Biol. Chem.
280: 25596-25603
[Abstract]
[Full Text]
-
WANG, X., MU, J., LI, G., CHEN, P., GUO, X., FU, L., CHEN, L., SU, X., WELLEMS, T. E.
(2005). DECREASED PREVALENCE OF THE PLASMODIUM FALCIPARUM CHLOROQUINE RESISTANCE TRANSPORTER 76T MARKER ASSOCIATED WITH CESSATION OF CHLOROQUINE USE AGAINST P. FALCIPARUM MALARIA IN HAINAN, PEOPLE'S REPUBLIC OF CHINA. Am J Trop Med Hyg
72: 410-414
[Abstract]
[Full Text]
-
Mariga, S. T., Gil, J. P., Sisowath, C., Wernsdorfer, W. H., Bjorkman, A.
(2004). Synergism between Amodiaquine and Its Major Metabolite, Desethylamodiaquine, against Plasmodium falciparum In Vitro. Antimicrob. Agents Chemother.
48: 4089-4096
[Abstract]
[Full Text]